Surge Therapeutics
Clinical trials sponsored by Surge Therapeutics, explained in plain language.
-
New drug injected during prostate surgery aims to improve outcomes
Disease control Recruiting nowThis early-phase trial tests a drug called STM-416p, which is given directly into the prostate area during surgery to remove the prostate (radical prostatectomy) in men with prostate cancer. The main goal is to check the drug's safety and find the best dose. About 18 men with int…
Phase: PHASE1 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug injected during bladder surgery aims to stop cancer from coming back
Disease control Recruiting nowThis early-stage trial tests a new drug called STM-416 that is given directly into the bladder during surgery to remove recurrent high-grade papillary bladder tumors. The study involves about 75 adults with a history of this cancer who are at high risk for it returning. The main …
Phase: PHASE1, PHASE2 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC